ProQR Therapeutics PRQR
NASDAQ PRQR
$1.67 +0.02 (+1.21%)
As of: Sep 30, 2026 · 10:13 AM EDT

ProQR Therapeutics (PRQR) Current Assets (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) reported Current Assets of $141.38 million for the quarter ended Jun 30, 2026, up 0.5% from $140.68 million a year earlier and up 38.8% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Current Assets (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics posted Current Assets of $113.12 million, down 32.1% from the prior year.

  • Current Assets has a five-year compound annual growth rate of 4.4% (years ended Dec 2020 to Dec 2025).
  • By year, Current Assets came in at $166.51 million in the year ended Dec 31, 2024 (+27.2%), $130.87 million in the year ended Dec 31, 2023 (-19.6%), $162.79 million in the year ended Dec 31, 2022 (-28.2%) and $226.6 million in the year ended Dec 31, 2021 (+148.0%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Current Assets since the quarter ended Mar 31, 2025.
  • Year over year, Current Assets gained in five of the last eight quarters, with growth averaging 3.0%.
  • The high point for year-over-year Current Assets in five years was the quarter ended Dec 31, 2021 (growth of 129.6%); the low point was the quarter ended Sep 30, 2022 (a decline of 49.7%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $101.83 million (quarter ended Mar 31, 2026), $116.55 million (quarter ended Dec 31, 2025) and $130.15 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 ProQR Therapeutics 173.85 Mn -289.75 Mn - 141.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141.38 Mn
Mar 31, 2026 101.83 Mn
Dec 31, 2025 116.55 Mn
Sep 30, 2025 130.15 Mn
Jun 30, 2025 140.68 Mn
Mar 31, 2025 145.25 Mn
Dec 31, 2024 164.40 Mn
Sep 30, 2024 101.49 Mn
Jun 30, 2024 109.59 Mn
Mar 31, 2024 116.41 Mn
Dec 31, 2023 130.17 Mn
Sep 30, 2023 135.73 Mn
Jun 30, 2023 142.81 Mn
Mar 31, 2023 152.00 Mn
Dec 31, 2022 157.59 Mn
Sep 30, 2022 104.97 Mn
Jun 30, 2022 171.86 Mn
Mar 31, 2022 193.57 Mn
Dec 31, 2021 219.05 Mn
Sep 30, 2021 208.80 Mn
API Access

ProQR Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=PRQR&period=max&api_key=YOUR_API_KEY